Allergy Therapeutics (AGY)

 

Latest News

All resolutions passed at AGM of Allergy Therapeutics

Allergy Therapeutics has announced that all resolutions were passed by shareholders at today's Annual General Meeting. A...

Result of AGM

RNS Number: 2447X Allergy Therapeutics PLC 22 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Result of Annual General Meeting 22 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces that, at its Annual General Meeting held this m...

Block Listing Application

RNS Number: 0383X Allergy Therapeutics PLC 21 November 2017 21 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Block Listing Application Allergy Therapeutics (AIM:AGY) , the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that an application has been made to the London Stoc...

Allergy Therapeutics to Present at Jefferies 2017

RNS Number: 2495W Allergy Therapeutics PLC 13 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics to Present at Jefferies 2017 London Healthcare Conference 13 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces th...

All News

DateHeadlineSource
20-11-13Allergy Therapeutics resolutions passed at AGMStockMarketWire
20-11-13Result of AGMRNS
20-11-13Allergy Therapeutics appoints R&D directorStockMarketWire
20-11-13Allergy Therapeutics revenues upStockMarketWire
20-11-13Business and R&D UpdateRNS
09-10-13Notification under AIM Rule Schedule Two (g)RNS
27-09-13Allergy Therapeutics appoints adviser StockMarketWire
27-09-13Change of AdviserRNS
19-09-13Holding(s) in CompanyRNS
16-09-13Allergy Therapeutics improves market shareStockMarketWire
16-09-13Final ResultsRNS
15-08-13Allergy Therapeutics schedules FY results StockMarketWire
15-08-13Notice of results and shareholder updateRNS
03-06-13Holding(s) in CompanyRNS
15-05-13Grant of OptionsRNS
08-05-13Holding(s) in CompanyRNS
08-05-13Holding(s) in CompanyRNS
25-03-13Half Yearly ReportRNS
11-03-13Allergy Therapeutics granted US patent StockMarketWire
11-03-13Notice of results and shareholder updateRNS
11-03-13US patent grantedRNS
01-02-13Total Voting RightsRNS
22-01-13Exercise of OptionsRNS
28-12-12Total Voting RightsRNS
27-12-12Update on Lincoln Medical FinalRNS
19-12-12Grant of OptionsRNS
10-12-12Director/PDMR ShareholdingRNS
05-12-12Total Voting RightsRNS
04-12-12Exercise of OptionsRNS
30-11-12Total Voting RightsRNS
21-11-12Holding(s) in CompanyRNS
20-11-12Exercise of OptionsRNS
14-11-12Result of AGMRNS
09-11-12Director/PDMR ShareholdingRNS
16-10-12Annual Financial ReportRNS
04-10-12Holding(s) in CompanyRNS
17-09-12Final ResultsRNS
30-08-12Notice of results and shareholder updateRNS
03-08-12Markets: FTSE 100 climbs higher on FridayInteractive Investor
03-08-12FDA Clinical Hold LiftedRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account